ACS Omega, 2017 · DOI: 10.1021/acsomega.7b01354 · Published: November 21, 2017
The study explores the use of reduced graphene oxide (rGO) microfibers as a potential substrate for neural growth and repair in damaged neural tissue, such as spinal cord injuries. The microfibers are coated with adhesive molecules (poly-L-lysine and N-cadherin) to support the growth of neurons and glial cells. In vivo studies show that these rGO microfibers can be implanted in the injured rat spinal cord without causing evident signs of subacute local toxicity, suggesting their potential for enhancing repair in damaged neural tissue.
rGO microfibers offer a promising platform for creating advanced biomaterials to treat neural diseases, especially spinal cord injuries.
N-cadherin coating can be used to selectively promote neural cell growth while hindering the growth of fibroblasts, improving the regenerative environment.
The feasible implantation and lack of subacute toxicity suggest that rGO microfibers are biocompatible and can be further developed for long-term in vivo applications.